
Julien De Salaberry
Decision Intelligence for Healthcare Innovation | CEO/Founder, Galen Growth (Creator of HealthTech Alpha) | Speaker | Board Advisor
🏢Galen Growth
📍Basel, Basel-Stadt, Switzerland
About
Overview Galen Growth helps healthcare organisations make more informed decisions about Digital Health innovation. We support corporate innovation, strategy, partnership and investment teams answering critical questions: Where is the market moving? Which companies and technologies matter? Which partners are ready to scale? Where are competitors placing their bets? What should we build, buy, partner with or invest in? Our work is powered by HealthTech Alpha, Galen Growth’s proprietary Digital Health intelligence platform. It combines globally structured company, product, funding, partnership, clinical, regulatory and market data with a specialist taxonomy and more than a decade of Digital Health expertise. Organisations use Galen Growth for market mapping, innovation scouting, partner identification, competitive intelligence, corporate venture strategy, M&A screening, commercial due diligence and portfolio assessment. We work with healthcare companies, investors, health systems and professional-services firms that need evidence they can defend—not simply more information. Contact Galen Growth to discuss your strategic question, request a HealthTech Alpha demonstration or commission a decision-grade market analysis. Website https://www.galengrowth.com Industry Research Services Company size 11-50 employees 19 associated members LinkedIn members who’ve listed Galen Growth | Decision-Grade Digital Health Intelligence as their current workplace on their profile. Founded 2016 Specialties Digital Health market intelligence, Healthcare innovation strategy, Digital Health scouting, Innovation partner identification, Corporate venture strategy, Digital Health M&A, Commercial due diligence, Private equity due diligence, Competitive intelligence, Healthcare market mapping, Digital Health partnerships, HealthTech investment intelligence, Portfolio assessment, Build-buy-partner analysis, and HealthTech Alpha